Cargando…
RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression
INTRODUCTION: Accumulating evidence indicates that RACK1 is involved in the progression of tumors. We aimed to evaluate the function of RACK1 in esophageal squamous cell carcinoma (ESCC) and its role in the mechanism of chemotherapy resistance. MATERIALS AND METHODS: Transfected ESCC cell lines with...
Autores principales: | Liu, Bowen, Wang, Cong, Chen, Pengxiang, Cheng, Bo, Cheng, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757499/ https://www.ncbi.nlm.nih.gov/pubmed/29379302 http://dx.doi.org/10.2147/OTT.S152818 |
Ejemplares similares
-
The prognostic significance of metabolic syndrome and weight loss in esophageal squamous cell carcinoma
por: Liu, Bowen, et al.
Publicado: (2018) -
Upregulation of the PI3K/Akt Pathway in the Tumorigenesis of Canine Thyroid Carcinoma
por: Campos, M., et al.
Publicado: (2014) -
Bcl-2 Is Involved in Cardiac Hypertrophy through PI3K-Akt Pathway
por: Meng, Xianwei, et al.
Publicado: (2021) -
Insulin upregulates betatrophin expression via PI3K/Akt pathway
por: Lu, Puhan, et al.
Publicado: (2017) -
Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway
por: Xu, Tao, et al.
Publicado: (2021)